SALIX PHARMS
Big PharmaSALIX PHARMS is a major pharmaceutical company focused on Gastroenterology, Oncology.
SALIX PHARMS's Key Drugs
SALIX PHARMS's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).
SALIX PHARMS's Recent FDA Approvals
New NDA/BLA approvals for SALIX PHARMS over the last two years — novel drugs only, excluding generics and label supplements.
SALIX PHARMS's Therapeutic Areas
SALIX PHARMS's approved drugs and pipeline span 2 therapeutic areas, led by Gastroenterology and Oncology, across 0 biologic and 3 small-molecule drugs. Weighted by commercial stage — approved drugs count most, then late-stage trials.
SALIX PHARMS's Top Competitors
SALIX PHARMS's closest competitors by therapeutic-area and drug-target overlap include Johnson & Johnson, Bristol-Myers Squibb, and Takeda. Ranked by overlap in therapeutic areas and drug targets across approved drugs and pipeline.
SALIX PHARMS Pipeline Snapshot
Active clinical trials for SALIX PHARMS across all therapeutic areas, from ClinicalTrials.gov.
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • Top drug revenue breakdown
- • Drug-level revenue analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Revenue forecasts • Trial milestones • Patent risk modeling
Active (0)
Discontinued (0)
Company Info
- First Approval
- 1961-10-06
- Latest
- 2024-07-23
- Applications
- 10